GENFIT S.A. - stock earnings
GNFT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | ? USD | 3.0 million USD |
| 2023Q2 | -22.7 million USD | 12.5 million USD |
| 2023Q1 | -14.5 million USD | 6.6 million USD |
| 2022Q4 | ? USD | 6.5 million USD |
| 2022Q3 | -6.5 million USD | 5.2 million USD |
| 2020Q2 | -29.8 million USD | 3.0 million USD |
| 2019Q2 | -29.1 million USD | 3.0 million USD |
| 2019Q1 | -28.7 million USD | 3.0 million USD |
| 2018Q4 | -25.7 million USD | 1.4 million USD |
| 2018Q3 | -26.2 million USD | 1.4 million USD |
| 2018Q2 | -2.2 million USD | 325396 USD |
| 2018Q1 | -2.5 million USD | 369903 USD |
GNFT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | ? USD | 22.5 million USD |
| 2022 | -25.5 million USD | 21.7 million USD |
| 2021 | 76.5 million USD | 91.1 million USD |
| 2020 | -123.3 million USD | 931674 USD |
| 2019 | -73.0 million USD | 34.5 million USD |
| 2018 | -91.0 million USD | 78935 USD |
| 2017 | -70.0 million USD | 140915 USD |
| 2016 | -35.4 million USD | 298820 USD |
| 2015 | -18.7 million USD | 576222 USD |
| 2014 | -20.7 million USD | 2.0 million USD |
| 2013 | -17.5 million USD | 2.6 million USD |
| 2012 | -7.1 million USD | 2.2 million USD |
| 2011 | -12.5 million USD | 3.1 million USD |
| 2010 | -12.5 million USD | 5.0 million USD |
| 2009 | -10.6 million USD | 8.3 million USD |
| 2008 | -5.5 million USD | 12.2 million USD |
| 2007 | -4.1 million USD | 13.8 million USD |
| 2006 | 432498 USD | 13.3 million USD |
| 2005 | 2.1 million USD | 15.1 million USD |
GNFT
Price: $3.50
52 week price:
Earnings Per Share: -0.83 USD
P/E Ratio: -4.40
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 944
Market Capitalization: 177.9 million